New Stock News | ICS Group's Hong Kong IPO prospectus has expired
ICS Corporate Services Group Inc. (referred to as: ICS Group) submitted its Hong Kong stock offering prospectus on February 10, 2026, which will expire after 6 months on August 10, 2026. Agricultural Bank of China International is its sole sponsor.
ICS Corporate Services Group Inc. (referred to as ICS Group) submitted its Hong Kong stock offering prospectus on February 10, 2026, which will expire on August 10, 2026, six months later. Agricultural Bank of China International is its sole sponsor.
According to the previous prospectus, ICS Group is a rapidly growing provider of professional services for Chinese enterprises going global, dedicated to assisting Chinese businesses in their overseas expansion. The company primarily offers comprehensive professional services in three major business areas: core businesscorporate services; fund administration services; and financial reporting and tax services.
According to a report by Frost & Sullivan, based on revenue in 2024, the company is the largest local service provider in China's professional services industry for businesses going global, with a market share of 10.5%. At the same time, it ranks second among all professional service providers for Chinese enterprises going global worldwide.
Related Articles

ZHENRO PPT (06158): An indirect wholly-owned subsidiary plans to restructure its nine corporate bonds listed on the Shanghai Stock Exchange.
.png)
A-share Pre-market Report | Yushu Technology (688836.SH) is participating in today's IPO! Single order profit may exceed 70,000 yuan.

Brokerage Morning Meeting Highlights | AI in Pharmaceuticals Has Great Potential, and the Industry Chain Is Expected to Continue Benefiting
ZHENRO PPT (06158): An indirect wholly-owned subsidiary plans to restructure its nine corporate bonds listed on the Shanghai Stock Exchange.

A-share Pre-market Report | Yushu Technology (688836.SH) is participating in today's IPO! Single order profit may exceed 70,000 yuan.
.png)
Brokerage Morning Meeting Highlights | AI in Pharmaceuticals Has Great Potential, and the Industry Chain Is Expected to Continue Benefiting

RECOMMEND





